Conversations

As we come upon the 10th anniversary of the Medicare Part D program, is it still living up to its promise? What can be done to improve it?

Contributors Respond

Dr. Bill Chin
,


Paul Howard, Ph.D
,


Conversations

Whether you're a patient, advocate or researcher, what are you most hopeful will emerge from the biopharmaceutical pipeline in the coming years?

Contributors Respond

Tom Frieden, MD, MPH
,


Robyn Swirling
,


Roberta DeBiasi, MD
,


Christophe Weber
,


Marla Weston, PhD, RN, FAAN
,


Conversations

Historically, vaccines have had an unmatched impact on improving public health. Looking ahead, what are the biggest obstacles and exciting opportunities in the field?

Contributors Respond

Pages

Subscribe to PhRMA RSS